With a 5.0-star rating on Google based on over 250 reviews, Movement Room is frequently recommended as one of the top choices ...

CEPI and POP BIO are committed to enabling equitable access to the outputs of their partnership, in line with CEPI’s ...

The Celcuity management team will host a webcast/conference call on Monday, July 28, 2025 at 8:00 a.m. ET to discuss the topline results from the Phase 3 VIKTORIA-1 trial. Those who would like to ...

Brent Morrison, CFA, Chairman and Chief Executive Officer of Regional, stated, “Regional is pleased that ISS concluded that support for this transaction was warranted. Regional is even more pleased ...

Dr. Shaltiel will present the Company’s exosome-based regenerative therapy platform at the Falling Walls Science Summit, taking place in Berlin, Germany from November 6-9, 2025. The winner, selected ...

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

Inidascamine was well-tolerated, with a favorable safety profile consistent with previous studies. Importantly, no evidence of sedation, weight gain, or extrapyramidal symptoms was observed, which are ...